Xenetic Biosciences Inc (XBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,726 | 11,995 | 13,097 | 13,848 | 14,927 |
| TOTAL | $12,045 | $12,871 | $13,653 | $14,167 | $15,376 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 704 | 844 | 1,067 | 1,406 | 1,092 |
| TOTAL | $704 | $844 | $1,067 | $1,406 | $1,092 |
| Total Assets | $12,749 | $13,716 | $14,720 | $15,573 | $16,468 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 221 | 259 | 287 | 203 | 473 |
| Accrued Expenses | 650 | 597 | 786 | 848 | 807 |
| TOTAL | $871 | $856 | $1,073 | $1,051 | $1,279 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $871 | $856 | $1,073 | $1,051 | $1,279 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,533 | 1,517 | 1,517 | 1,517 | 1,432 |
| Common Shares | 2 | 15 | 2 | 14 | 14 |
| Retained earnings | -191,007 | -189,956 | -189,100 | -187,617 | -186,813 |
| Other shareholders' equity | -27 | -28 | -28 | -27 | -25 |
| TOTAL | $11,878 | $12,859 | $13,647 | $14,522 | $15,192 |
| Total Liabilities And Equity | $12,749 | $13,716 | $14,720 | $15,573 | $16,471 |